International Clinical Trial: Evaluating the Safety and Completion Rates of an Optimized 3HP Regimen versus the Standard 3HP Regimen for Latent Tuberculosis Infection in Hemodialysis Patients: A Randomized Controlled Trial

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115544) titled 'Evaluating the Safety and Completion Rates of an Optimized 3HP Regimen versus the Standard 3HP Regimen for Latent Tuberculosis Infection in Hemodialysis Patients: A Randomized Controlled Trial' on Dec. 29, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shanghai Public Health Clinical Center

Condition: Latent tuberculosis infection during hemodialysis

Intervention: Experimental Group (Optimized 3HP:Reduced-dose 3HP (Isoniazid 900mg/week + Rifapentine 600mg/week)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-12-31

Target Sample Size: Exper...